Open Access

[Retracted] MicroRNA‑425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‑derived growth factor

  • Authors:
    • Wenyan Zhu
    • Yongchi Ma
    • Xuqin Zhuang
    • Xin Jin
  • View Affiliations

  • Published online on: January 22, 2024     https://doi.org/10.3892/ol.2024.14245
  • Article Number: 112
  • Copyright : © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Lett 15: [Related article:] 6345–6351, 2018; DOI: 10.3892/ol.2018.8128

Following the publication of the above article, a concerned reader drew to the Editor's attention that the Transwell cell migration and invasion assay data featured in Figs. 3B and 6C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Letters, or were under consideration for publication at around the same time (some of which have been retracted).

In view of the fact that certain of these data had already apparently been published prior to the submission of this article for publication, the Editor of Oncology Letters has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

March-2024
Volume 27 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhu W, Ma Y, Zhuang X and Jin X: [Retracted] MicroRNA‑425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‑derived growth factor. Oncol Lett 27: 112, 2024
APA
Zhu, W., Ma, Y., Zhuang, X., & Jin, X. (2024). [Retracted] MicroRNA‑425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‑derived growth factor. Oncology Letters, 27, 112. https://doi.org/10.3892/ol.2024.14245
MLA
Zhu, W., Ma, Y., Zhuang, X., Jin, X."[Retracted] MicroRNA‑425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‑derived growth factor". Oncology Letters 27.3 (2024): 112.
Chicago
Zhu, W., Ma, Y., Zhuang, X., Jin, X."[Retracted] MicroRNA‑425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‑derived growth factor". Oncology Letters 27, no. 3 (2024): 112. https://doi.org/10.3892/ol.2024.14245